Skip to main content

Table 2 Comparison of mean CD4 cell counts: Intergroup and intragroup comparison of mean CD4 cell counts for the virally suppressed group, treatment failure group and low level viremia group at different time points

From: Pre-treatment minority HIV-1 drug resistance mutations and long term virological outcomes: is prediction possible?

 

Virally suppressed group

Virological failure group

Low level viremia group

Any viremia group

P-value (α = 5 %)

Baseline CD4 cell count (cells/μl)

n = 45, Mean = 199

n = 8, Mean = 183

  

0.74

n = 45, Mean = 199

 

n = 12, Mean = 181

 

0.66

n = 45, Mean = 199

  

n = 20, Mean = 182

0.61

 

n = 8, Mean = 183

n = 12, Mean = 181

 

0.97

CD4 cell count @ 6–12 months after treatment initiation (cells/μl)

n = 18, Mean = 387

n = 8, Mean = 250

  

0.18

n = 18, Mean = 387

 

n = 9, Mean = 438

 

0.58

n = 18, Mean = 387

  

n = 17, Mean = 350

0.64

 

n = 8, Mean = 250

n = 9, Mean = 438

 

0.07

P-value (α = 5 %)

0.0001

0.47

0.001

0.01

Â